Linda M Griffith Selected Research

Linda M Griffith Research Topics

10	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022 - 12/2008
8	Multiple Sclerosis 09/2021 - 08/2010
7	Primary Immunodeficiency Diseases 01/2020 - 12/2008
4	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 11/2005
3	Infections 01/2022 - 06/2017
3	Relapsing-Remitting Multiple Sclerosis 09/2021 - 02/2015
2	Chronic Granulomatous Disease 01/2022 - 01/2016
2	Bronchiolitis Obliterans Syndrome 01/2022 - 05/2015
2	Wiskott-Aldrich Syndrome 01/2020 - 01/2016
2	Reticular dysgenesis 12/2017 - 04/2014
2	Systemic Scleroderma (Systemic Sclerosis) 09/2017 - 05/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2017 - 02/2004
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2022
1	Cytopenia 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2018
1	Opportunistic Infections (Opportunistic Infection) 06/2017
1	Hematologic Neoplasms (Hematological Malignancy) 03/2014
1	Acute Kidney Injury (Acute Renal Failure) 05/2011
1	Communicable Diseases (Infectious Diseases) 12/2009
1	Rare Diseases (Rare Disease) 12/2009
1	Neoplasms (Cancer) 02/2004

1	AntibodiesIBA 01/2022
1	Adenosine DeaminaseIBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Investigational DrugsIBA 09/2017
1	Pharmaceutical PreparationsIBA 09/2017
1	VaccinesIBA 06/2017
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	EnzymesIBA 04/2014
1	gamma-Globulins (gamma-Globulin)IBA 12/2009
1	ElementsIBA 12/2009
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2004
1	fludarabineIBA 02/2004

19	Cell Transplantation 01/2022 - 06/2006
11	Therapeutics 01/2022 - 06/2006
8	Transplantation 01/2020 - 12/2009
5	Hematopoietic Stem Cell Transplantation 01/2020 - 11/2005
2	Drug Therapy (Chemotherapy) 12/2017 - 02/2004
2	Stem Cell Transplantation 03/2014 - 02/2004
1	Autologous Transplantation 02/2017